iCoreConnect Inc. Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2024-12-31..
- Stock-based compensation / revenue · 12 months: Value 66.39%; Formula and calculation Share-based compensation / revenue. Period ending 2024-12-31..
- Interest coverage · 12 months: Value -10.86×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2024-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2024-12-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 66.39% | Share-based compensation / revenue. Period ending 2024-12-31. $7.13M ÷ $10.75M × 100 ≈ 66.39% |
| Interest coverage · 12 months | -10.86× | Operating income ÷ reported interest expense. $-15.51M ÷ $1.43M ≈ -10.86× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 10.75M USD | |
| Stock-based compensation | 7.13M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -15.51M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 1.43M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | (m) | $10.75M | $7.13M | $-15.51M | $1.43M | (m) | 66.39% | -10.86× | Reported |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $8.15M | $1.94M | $-10.28M | $1.11M | (m) | 23.82% | -9.26× | Reported |
| 2023-09-30 | (m) | $7.75M | $2.37M | $-7.41M | $1.23M | (m) | 30.58% | -6.02× | Reported |
| 2023-08-25 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | $-7.96M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | $1.73M | $-6.04M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $7.99M | $1.72M | $-4.80M | $785.41K | (m) | 21.50% | -6.11× | Reported |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | $-1.80K | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.